Stockscreener 앱 받기
32.02
0.53%
0.17
시간 외 거래:
32.02
Surrozen Inc 주식(SRZN)의 최신 뉴스
Surrozen (SRZN) Surges 5.9%: Is This an Indication of Further Gains? - Yahoo Finance
(SRZN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Aug Ideas: How liquid is Surrozen Inc stock2026 Analyst Calls & Advanced Technical Signal Analysis - baoquankhu1.vn
SRZN Stock Price, Quote & Chart | SURROZEN INC (NASDAQ:SRZN) - ChartMill
Merck Wnt first, Surrozen goes next in AMD, DME - BioWorld News
Published on: 2026-04-08 02:43:17 - baoquankhu1.vn
SRZN PE Ratio & Valuation, Is SRZN Overvalued - Intellectia AI
Responsive Playbooks and the SRZN Inflection - Stock Traders Daily
Surrozen (SRZN) EVP Li Yang donates 1,666 common shares in Form 4 - Stock Titan
[ARS] Surrozen, Inc./DE SEC Filing - Stock Titan
Executive pay and board elections headline Surrozen (NASDAQ: SRZN) 2026 meeting - Stock Titan
[EFFECT] Surrozen, Inc./DE SEC Filing - Stock Titan
Surrozen (NASDAQ: SRZN) sets $50M ATM shelf with TD Cowen - Stock Titan
Short Squeeze: Should value investors consider Surrozen Inc Equity Warrant2026 Chart Watch & Long-Term Growth Stock Strategies - baoquankhu1.vn
Surrozen (NASDAQ:SRZN) Upgraded at Wall Street Zen - Defense World
Tcg Crossover Gp Ii, Llc Acquires 106,658 Shares of Surrozen (NASDAQ:SRZN) Stock - Defense World
What is Lifesci Capital’s Forecast for Surrozen Q1 Earnings? - Defense World
Breakout Zone: Is Surrozen Inc Equity Warrant attractive for institutional investorsRate Cut & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Wednesday’s insider activity: Major buys at Surrozen and MGM Resorts - Investing.com
Guggenheim Keeps Their Buy Rating on Surrozen (SRZN) - The Globe and Mail
What is Lifesci Capital's Forecast for Surrozen Q1 Earnings? - MarketBeat
What is HC Wainwright's Forecast for Surrozen Q1 Earnings? - MarketBeat
Guidance Update: Can Surrozen Inc Equity Warrant lead its sector in growth2026 Buyback Activity & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
HC Wainwright Forecasts Surrozen FY2030 Earnings - Defense World
Insider Buying: Surrozen (NASDAQ:SRZN) Major Shareholder Buys $2,633,386.02 in Stock - MarketBeat
Surrozen (NASDAQ:SRZN) Major Shareholder Buys $379,052.70 in Stock - MarketBeat
TCG Crossover funds boost Surrozen (SRZN) stake with open-market buys - stocktitan.net
TCG crossover funds buys Surrozen (SRZN) shares worth $3m By Investing.com - Investing.com South Africa
TCG crossover funds buys Surrozen (SRZN) shares worth $3m - Investing.com
Earnings Risk: Is Surrozen Inc a cyclical or defensive stock2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn
Cantor Fitzgerald Sticks to Their Buy Rating for Surrozen (SRZN) - The Globe and Mail
HC Wainwright Weighs in on Surrozen FY2030 Earnings - MarketBeat
Fed Meeting: Is Surrozen Inc Equity Warrant forming a bullish divergence2026 Price Momentum & Low Drawdown Trading Strategies - baoquankhu1.vn
SRZNW SEC FilingsSurrozen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: CSL (CMXHF), Surrozen (SRZN) - The Globe and Mail
Guggenheim reiterates Surrozen stock rating on pipeline progress By Investing.com - Investing.com Canada
Guggenheim reiterates Surrozen stock rating on pipeline progress - Investing.com UK
Cantor Fitzgerald Reaffirms Overweight Rating for Surrozen (NASDAQ:SRZN) - MarketBeat
Cantor Fitzgerald reiterates Overweight on Surrozen stock at $40 By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Overweight on Surrozen stock at $40 - Investing.com UK
Surrozen's (SRZN) Buy Rating Reaffirmed at HC Wainwright - marketbeat.com
SRZN: HC Wainwright & Co. Raises Price Target to $36, Reiterates Buy Rating | SRZN Stock News - GuruFocus
Surrozen Reports 2025 Financial Results, Advances Retinal Disease Therapies, and Announces $5M Milestone from Boehringer Ingelheim - Minichart
Surrozen, Inc. 2025 Annual Report: Advancing Wnt Pathway Modulation for Ophthalmic Disease Treatment 50 - Minichart
Surrozen Reports Q4 and Full Year 2025 Financial Results, Provides Business UpdateSouth San Francisco Today - National Today
Surrozen (NASDAQ: SRZN) files $200M shelf to sell stock, debt, warrants - Stock Titan
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network
Surrozen (NASDAQ:SRZN) Releases Earnings Results, Misses Expectations By $6.30 EPS - MarketBeat
Surrozen 10-K: Revenue $3.48M, EPS $(32.37) — steep net loss from financing charges - TradingView
[10-K] Surrozen, Inc./DE Files Annual Report - Stock Titan
Surrozen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
SRZN: Cash rose to $89M, net loss widened to $242M, IND for SZN-8141 expected H2 2026 - TradingView
Surrozen (NASDAQ: SRZN) posts 2025 loss but boosts cash for eye programs - Stock Titan
BRIEF-Surrozen FY EPS USD -32.37 - TradingView
$5M milestone moves Surrozen toward an eye drug IND filing - Stock Titan
Surrozen (SRZN) to Release Quarterly Earnings on Monday - Defense World
Understanding the Setup: (SRZN) and Scalable Risk - Stock Traders Daily
2.69%
0.25%
자본화:
|
볼륨(24시간):